News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Robert Huisden

Articles by Robert Huisden

4 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab (D) as First-Line (1L) Treatment for Unresectable Locally Advanced/ Metastatic Triple-Negative Breast Cancer (a/mTNBC): Updated Results From BEGONIA, a Phase 1b/2 Study

ByJamil Asselah,Cynthia X. Ma, MD, PhD,Zbigniew Nowecki,Robert Huisden,Ross Stewart,Petra Vuković,Peter Schmid, MD

April 28th 2023

Latest Updated Articles

Trending on CancerNetwork

How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research

Chlorotoxin-Directed Cell Therapy May Have Useful Mechanism in Glioblastoma

Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC

Radioembolization Plus Chemotherapy Is Feasible in Liver-Dominant NETs

Pembrolizumab Regimen May Show Synergy in Melanoma Populations

© 2025 MJH Life Sciences^®

All rights reserved.